X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11941) 11941
Newsletter (473) 473
Newspaper Article (51) 51
Book Chapter (46) 46
Magazine Article (42) 42
Dissertation (40) 40
Conference Proceeding (8) 8
Web Resource (6) 6
Book Review (2) 2
Journal / eJournal (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
itraconazole (8663) 8663
humans (6872) 6872
male (3759) 3759
antifungal agents - therapeutic use (3671) 3671
female (2949) 2949
itraconazole - therapeutic use (2777) 2777
adult (2414) 2414
pharmacology & pharmacy (2394) 2394
middle aged (2043) 2043
microbiology (2004) 2004
antifungal agents - pharmacology (1994) 1994
fluconazole (1952) 1952
voriconazole (1646) 1646
infectious diseases (1528) 1528
antifungal agents - administration & dosage (1436) 1436
animals (1400) 1400
itraconazole - pharmacology (1324) 1324
microbial sensitivity tests (1284) 1284
mycology (1281) 1281
treatment outcome (1217) 1217
antifungal agents (1208) 1208
aged (1200) 1200
itraconazole - administration & dosage (1180) 1180
amphotericin-b (1166) 1166
dermatology (1118) 1118
mycoses (931) 931
terbinafine (914) 914
administration, oral (858) 858
amphotericin b (848) 848
amphotericin b - therapeutic use (823) 823
adolescent (803) 803
pharmacokinetics (777) 777
ketoconazole (761) 761
infections (757) 757
therapy (745) 745
drug interactions (728) 728
aspergillosis (707) 707
aspergillosis - drug therapy (706) 706
research (676) 676
posaconazole (667) 667
diagnosis (666) 666
fluconazole - pharmacology (642) 642
infection (640) 640
child (620) 620
immunology (618) 618
mycoses - drug therapy (611) 611
susceptibility (611) 611
triazoles - pharmacology (604) 604
fungi (603) 603
health aspects (602) 602
antifungal agents - adverse effects (598) 598
veterinary sciences (598) 598
drugs (586) 586
amphotericin b - pharmacology (575) 575
analysis (563) 563
in-vitro (554) 554
fluconazole - therapeutic use (548) 548
onychomycosis (541) 541
epidemiology (528) 528
care and treatment (525) 525
ketoconazole - therapeutic use (509) 509
drug therapy, combination (503) 503
antifungal agents - pharmacokinetics (483) 483
ketoconazole - analogs & derivatives (476) 476
drug resistance, fungal (474) 474
drug therapy (472) 472
invasive aspergillosis (460) 460
fungal infections (455) 455
medicine, general & internal (454) 454
fungal-infections (450) 450
onychomycosis - drug therapy (449) 449
triazoles - therapeutic use (444) 444
aspergillus (442) 442
candida - drug effects (438) 438
solubility (423) 423
resistance (414) 414
immunocompromised host (406) 406
itraconazole - adverse effects (397) 397
dermatology & venereal diseases (392) 392
antifungal (372) 372
double-blind (371) 371
aids (369) 369
dermatomycoses - drug therapy (369) 369
itraconazole - pharmacokinetics (366) 366
mice (366) 366
retrospective studies (366) 366
efficacy (358) 358
young adult (356) 356
diagnosis, differential (352) 352
azoles (349) 349
risk factors (342) 342
transplantation (342) 342
caspofungin (341) 341
ketoconazole - pharmacology (340) 340
aspergillus fumigatus - drug effects (332) 332
aspergillosis - microbiology (329) 329
pyrimidines - pharmacology (326) 326
mycoses - microbiology (325) 325
dose-response relationship, drug (324) 324
histoplasmosis - drug therapy (322) 322
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11426) 11426
French (352) 352
German (303) 303
Spanish (277) 277
Japanese (271) 271
Portuguese (167) 167
Chinese (62) 62
Polish (48) 48
Korean (46) 46
Italian (37) 37
Turkish (36) 36
Dutch (24) 24
Russian (23) 23
Czech (10) 10
Bulgarian (6) 6
Persian (6) 6
Finnish (5) 5
Romanian (3) 3
Slovenian (3) 3
Serbian (2) 2
Swedish (2) 2
Danish (1) 1
Galician (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Toxicology letters, ISSN 0378-4274, 10/2015, Volume 238, Issue 2, pp. S194 - S194
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 11/2017, Volume 44, Issue 11, pp. 1083 - 1088
Journal Article
Journal Article
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2018, Volume 2018, Issue 8, p. CD004773
Background Cryptococcal disease remains one of the main causes of death in HIV‐positive people who have low cluster of differentiation 4 (CD4) cell counts.... 
HIV/AIDS | Primary Prevention | Fluconazole | HIV Seropositivity | Cryptococcosis | Other complications/co‐morbidities: treatment | CD4 Lymphocyte Count | Cause of Death | Randomized Controlled Trials as Topic | Prevention | Infectious disease | HIV | AIDS‐Related Opportunistic Infections | Candida | Antifungal Agents | Prevention: other | Medicine General & Introductory Medical Sciences | Drug Resistance, Fungal | Itraconazole | OROPHARYNGEAL CANDIDIASIS | CONTROLLED TRIAL | Itraconazole [therapeutic use] | Meningitis, Cryptococcal [prevention & control] | IMMUNODEFICIENCY-VIRUS-INFECTION | Humans | FLUCONAZOLE PROPHYLAXIS | OPPORTUNISTIC INFECTIONS | ANTIRETROVIRAL THERAPY | ITRACONAZOLE PROPHYLAXIS | FUNGAL-INFECTIONS | MEDICINE, GENERAL & INTERNAL | Antifungal Agents [therapeutic use] | RECEIVING FLUCONAZOLE | AIDS-Related Opportunistic Infections [prevention & control] | Cryptococcosis [prevention & control] | DOUBLE-BLIND | Adult | Fluconazole [therapeutic use] | Antifungal Agents - adverse effects | HIV Seropositivity - complications | Cryptococcosis - prevention & control | Fluconazole - adverse effects | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | AIDS-Related Opportunistic Infections - prevention & control | Itraconazole - adverse effects | Cryptococcosis - mortality | Candida - drug effects | Child | HIV Seropositivity - immunology
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e21237
The Plasmodium falciparum lactate dehydrogenase enzyme (PfLDH) has been considered as a potential molecular target for antimalarials due to this parasite's... 
DRUG-SENSITIVITY | PARASITES | IN-VITRO | QUINOLINE ANTIMALARIALS | NATURAL-PRODUCTS | BIOLOGY | RESISTANCE | MALARIA | CHLOROQUINE | MOLECULAR DOCKING | CULTURE | L-Lactate Dehydrogenase - metabolism | Plasmodium falciparum - enzymology | Triazoles - chemistry | Heptanoic Acids - therapeutic use | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemistry | Plasmodium falciparum - drug effects | Itraconazole - pharmacology | Pyrroles - therapeutic use | Heptanoic Acids - pharmacology | Triazoles - therapeutic use | Catalytic Domain | Enzyme-Linked Immunosorbent Assay | Cells, Cultured | Antimalarials - therapeutic use | Itraconazole - chemistry | Antimalarials - pharmacology | Itraconazole - therapeutic use | Triazoles - pharmacology | Atorvastatin Calcium | Pyrroles - pharmacology | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Heptanoic Acids - chemistry | Antimalarials - chemistry | Pyrroles - chemistry | Mice | Malaria - drug therapy | L-Lactate Dehydrogenase - antagonists & inhibitors | Plasmodium falciparum | Malaria | Analysis | Force and energy | Antimalarials | B cells | Itraconazole | Drugs | Dehydrogenases | Laboratories | Chloroquine | Erythrocytes | Parasites | Dehydrogenase | Drug resistance | Molecular docking | Proteins | Analogs | Toxicology | Histidine | NADH | Parasitic diseases | Parasitemia | Active control | Vector-borne diseases | Enzymes | Antigens | Polymerization | Lactate dehydrogenase | Medical screening | L-Lactate dehydrogenase | Chemotherapy | Antimalarial activity | Inhibitors | Blood parasites | Natural products | Antimalarial agents | Computer applications | Nicotinamide adenine dinucleotide | Glycolysis | Atorvastatin | Lactic acid | Posaconazole
Journal Article
Cancer cell, ISSN 1535-6108, 01/2013, Volume 23, Issue 1, pp. 23 - 34
Journal Article
Materials Science and Engineering: C, ISSN 0928-4931, 2019, Volume 99, pp. 231 - 240
Journal Article